ShanDong Confucian Biologics Co. Ltd. announced unaudited earnings results for the second quarter and six months ended June 30, 2016. For the quarter, sales revenue was $144,316, loss from operation was $98,049, loss before income taxes was $118,377 and net loss was $118,377 against loss from operation of $15,953, loss before income taxes of $27,241 and net loss of $27,241 for the same period a year ago. For the six months, sales revenue was $306,077, loss from operation was $211,685, loss before income taxes was $246,681 and net loss was $246,681 against loss from operation of $165,525, loss before income taxes of $213,248 and net loss of $213,248 for the same period a year ago. Cash used in operating activities was $515,218 against $61,828 a year ago. Purchase of property and equipment was $488,122 against $140,270 a year ago.